CTRI/2020/09/027691
Completed
未知
A pilot study to determine whether respiratory-responsice vocal biomarkers (RRVB) either alone or in combination with symptom inventory can identify Covid-19 patients versus asymptomatic healthy controls. - SH2020.COV01
Sonde Health0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- Sonde Health
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Own an eligible smartphone (iOS or Android) that is able to download and run the Sonde Health app (access to smartphone provided by parent or legal guardian of participants under the age 18 is allowed)
- •2 Willing to sign up for a Sonde app account
- •3 Agreement with the subject consent information presented on the Sonde app. In case of adolescent subjects, agreement with subject consent information provided by a parent or legal guardian
- •4 Stated willingness and ability to comply with all study procedures for the duration of the study
- •5 Male or female, aged 12 or above (including adults)
- •6 Able to read and speak English or Marathi (required to follow app instructions and provide correct voice elicitations)
- •7 Pregnant women are allowed to participate
- •Only for subjects in subgroups 1a and 1b (suspected COVID\-19 patients):
- •8 Confirmed or suspected COVID\-19 infection with mild or severe illness severity at screening on Day 1
- •9 Suspected COVID\-19 includes patients having at least one of the following symptoms that are present at most 10 days prior to enrollment:
Exclusion Criteria
- •An individual who meets any of the following criteria will be excluded from participation in this study:
- •1\. Difficulties with speech production
- •2\. Difficulties reading or responding to instructions and questions on a smartphone screen
- •3\. Critical COVID\-19 illness severity at screening on Day 1
- •4\. Other critical health condition where study participation would place unreasonable burden or risk on the patient as determined by the study site principal investigator
- •For subjects in subgroup 2:
- •5\. History of positive COVID\-19 viral or serologic test result any time prior to enrollment
- •6\. Any hospital staff that is a member of the study team, and staff in the pulmonary and infectious disease departments of the participating institution, or any of their co\-living family members
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pilot study to investigate the impact of Respiratory Gated Positron Emission Tomography (PET) scanning on classification and diagnostic accuracy in patients with Solitary Pulmonary nodulesSolitary Pulmonary Nodules (SPN)Cancer - Other cancer typesACTRN12610000790044Peter MacCallum Cancer Centre1
Recruiting
Not Applicable
A pilot study on delivery suite mask ventilation in extremely preterm infantseonatal resuscitationExtremely preterm infantsNeonatal resuscitationReproductive Health and Childbirth - Complications of newbornPublic Health - Health service researchRespiratory - Normal development and function of the respiratory systemACTRN12614000245695eonatal Intensive Care Unit, Westmead Hospital40
Completed
Not Applicable
A study comparing different types of breathing supports in robotic surgeriesCTRI/2019/09/021289arayana Hrudayalaya
Completed
Not Applicable
Prospective observational study on respiratory surgery pain and pre- and postoperative examinatioJPRN-UMIN000049049SHOWA University Northern Yokohama Hospital100
Completed
Not Applicable
Inspiratory muscle training and exercise goal setting to improve functional ability and relieve the symptoms of dyspnoea in advanced cancer patientsISRCTN30501538niversity of Derby (UK)40